Compile Data Set for Download or QSAR
Report error Found 26 of ic50 data for polymerid = 1013
TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486503(US10947241, Example 46)
Affinity DataIC50: 300nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486516(US10947241, Example 91)
Affinity DataIC50: 600nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486504(US10947241, Example 47)
Affinity DataIC50: 700nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486505(US10947241, Example 51)
Affinity DataIC50: 800nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486513(US10947241, Example 88)
Affinity DataIC50: 900nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486515(US10947241, Example 90)
Affinity DataIC50: 900nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486491(US10947241, Example 1)
Affinity DataIC50: 1.00E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486507(US10947241, Example 57)
Affinity DataIC50: 1.00E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486497(US10947241, Example 10)
Affinity DataIC50: 1.20E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486501(US10947241, Example 43)
Affinity DataIC50: 1.30E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486502(US10947241, Example 45)
Affinity DataIC50: 1.60E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486495(US10947241, Example 4)
Affinity DataIC50: 1.60E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486512(US10947241, Example 87)
Affinity DataIC50: 1.70E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486514(US10947241, Example 89)
Affinity DataIC50: 1.80E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486506(US10947241, Example 54)
Affinity DataIC50: 1.90E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486517(US10947241, Example 93)
Affinity DataIC50: 1.90E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486509(US10947241, Example 60)
Affinity DataIC50: 1.90E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486518(US10947241, Example 95)
Affinity DataIC50: 2.30E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486499(US10947241, Example 36)
Affinity DataIC50: 2.50E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486508(US10947241, Example 58)
Affinity DataIC50: 2.90E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486498(US10947241, Example 34)
Affinity DataIC50: 3.00E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486496(US10947241, Example 9)
Affinity DataIC50: 3.70E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486492(US10947241, Example 2)
Affinity DataIC50: 5.00E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486510(US10947241, Example 85)
Affinity DataIC50: 5.40E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486500(US10947241, Example 38)
Affinity DataIC50: 7.90E+3nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetResistin(Human)
Seoul National University Hospital

US Patent
LigandPNGBDBM486511(US10947241, Example 86)
Affinity DataIC50: 1.80E+4nMAssay Description:Using THP-1 (human monocyte) cell line and ELISA system, the abilities to inhibit TNF-α secretion by hResistin (IC50) were evaluated for the com...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent